Effectiveness of medium-dose intravenous immunoglobulin (1 g/kg) in the treatment of kawasaki disease

Korean Circulation Journal

Volumn 40, Issue 2, 2010, Pages 81-85

  Yeo, Joong Seok ^a   Choi, Jong Woon ^a  

^a Bundang Jesaeng Hospital   (South Korea)

Author keywords

Immunoglobulin; Intravenous infusions; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; HEMOGLOBIN; IMMUNOGLOBULIN;

AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTERY LESION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY; CORONARY ARTERY ANEURYSM; COST EFFECTIVENESS ANALYSIS; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEX RATIO; SINGLE DRUG DOSE; THROMBOCYTE COUNT;

EID: 77949378384     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2010.40.2.81     Document Type: Article

References (19)

1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114: 1708-33.
2. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991; 119: 279-82.
3. Engle MA, Fatica NS, Bussel JB, O'Loughlin JE, Snyder MS, Lesser ML. Clinical trial of single-dose intravenous gamma globulin in acute Kawasaki disease: preliminary report. Am J Dis Child 1989; 143: 1300-4.
4. Furusho K, Kamiya T, Nakano H, et al. Intravenous gammaglobulin for Kawasaki disease. Acta Paediatr Jpn 1991; 33: 799-804.
5. Barron KS, Murphy DJ, Silverman ED, et al. Treatment of Kawasaki syndrome: a comparison of two dosage regimens of intravenously administered immune globulin. J Pediatr 1990; 117-638-44.
6. Ihn SM, Ann RZ, Kil HR, Chung YH. Selective gamma globulin treatment in Kawasaki disease: the comparison between single 1 g/kg and 2 g/kg. J Korean Pediatr Soc 2000; 43: 920-5.
7. Qin LJ, Wang HW, Hu XF, et al. Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study. Zhonghua Er Ke Za Zhi 2006; 44: 891-5.
8. Han SB, Choi JW, Kim SK, Chung SW, Kim JG, Son BK. The optimal dosages of gammaglobulin and aspirin in treating Kawasaki disease. J Korean Pediatr Soc 1996; 39: 703-11.
9. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-80.
10. Choi CH, Byun SH, Jeon JD, Choi JW. Usefulness of echocardiography findings in the early diagnosis of Kawasaki disease. J Korean Pediatr Soc 2007; 50: 47-51.
11. Furusho K, Nakano H, Shinomiya K, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984; 2: 1055-8.
12. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991; 324: 1633-9.
13. Kang MK, Cho EY, Kim YH, et al. Treatment of Kawasaki disease with single high-dose intravenous gammaglobulin. J Korean Pediatr Soc 1992; 35: 342-8.
14. Moon SY, Kim NS, Lee HB, Lee H. Comparative study about the therapeutic effect between single and five-day administration of gammaglobulin in Kawasaki disease. Korean Circ J 1994; 24-77-85.
15. Park YW, Han JW, Park IS, et al. Kawasaki disease in Korea, 2003-2005. Pediatr Infect Dis J 2007; 26: 821-3.
16. Research Committee on Kawasaki Disease. Reports of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo: Ministry of Health and Welfare; 1983. p.48-54.
17. Nakano H, Ueda K, Saito A, Nojima K. Repeated quantitative angiograms in coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 1985; 56: 846-51.
18. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-8.
19. Takahashi M. Kawasaki syndrome (mucocutaneous lymph node syndrome). In: Allen HD, Gutgesell HD, Clark EB, Driscoll DJ editors. Moss and Adams Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p.1216-25.